Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce M Hall

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|February 27, 2026
Cytokines Associated with Activation of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T Regulatory CellsRanje Al-Atiyah, Nirupama D Verma, Giang T Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cordsGiang T Tran, Suzanne J Hodgkinson, Nicole Carter, et al.
Transplantation|November 30, 2006
Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide productionNirupama D Verma, Rochelle Boyd, Catherine Robinson, et al.
Scientific Reports|May 19, 2021
Multiple sclerosis patients have reduced resting and increased activated CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup>T regulatory cellsNirupama D Verma, Andrew D Lam, Christopher Chiu, et al.
Transplant Immunology|April 26, 2006
The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or toleranceMasaru Nomura, Karren M Plain, Nirupama Verma, et al.
Transplant Immunology|March 3, 2007
IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activationCassandra Davidson, Nirupama D Verma, Catherine M Robinson, et al.
Transplantation|April 7, 2007
Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administrationKarren M Plain, Rochelle Boyd, Nirupama D Verma, et al.
Frontiers in Immunology|August 13, 2013
Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?Bruce M Hall, Giang T Tran, Nirupama D Verma, et al.
Transplant Immunology|May 11, 2017
Cytokines affecting CD4<sup>+</sup>T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4<sup>+</sup>T regulatory cellsMasaru Nomura, Suzanne J Hodgkinson, Giang T Tran, et al.
Blood|October 2, 2008
CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responsesNirupama D Verma, Karren M Plain, Masaru Nomura, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|February 27, 2026
Cytokines Associated with Activation of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T Regulatory CellsRanje Al-Atiyah, Nirupama D Verma, Giang T Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cordsGiang T Tran, Suzanne J Hodgkinson, Nicole Carter, et al.
Transplantation|November 30, 2006
Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide productionNirupama D Verma, Rochelle Boyd, Catherine Robinson, et al.
Scientific Reports|May 19, 2021
Multiple sclerosis patients have reduced resting and increased activated CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup>T regulatory cellsNirupama D Verma, Andrew D Lam, Christopher Chiu, et al.
Transplant Immunology|April 26, 2006
The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or toleranceMasaru Nomura, Karren M Plain, Nirupama Verma, et al.
Transplant Immunology|March 3, 2007
IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activationCassandra Davidson, Nirupama D Verma, Catherine M Robinson, et al.
Transplantation|April 7, 2007
Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administrationKarren M Plain, Rochelle Boyd, Nirupama D Verma, et al.
Frontiers in Immunology|August 13, 2013
Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?Bruce M Hall, Giang T Tran, Nirupama D Verma, et al.
Transplant Immunology|May 11, 2017
Cytokines affecting CD4<sup>+</sup>T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4<sup>+</sup>T regulatory cellsMasaru Nomura, Suzanne J Hodgkinson, Giang T Tran, et al.
Blood|October 2, 2008
CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responsesNirupama D Verma, Karren M Plain, Masaru Nomura, et al.
Pageof 4